Shares of Research Frontiers, Inc. (NASDAQ:REFR) passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $3.11 and traded as low as $2.99. Research Frontiers shares last traded at $3.05, with a volume of 1,668 shares changing hands.
Separately, ValuEngine cut shares of Zosano Pharma from a “buy” rating to a “hold” rating in a research report on Wednesday, May 1st.
The firm’s 50-day moving average price is $3.11. The company has a current ratio of 11.47, a quick ratio of 11.47 and a debt-to-equity ratio of 0.28. The stock has a market capitalization of $88.71 million, a PE ratio of -34.33 and a beta of 1.10.
In other Research Frontiers news, VP Michael R. Lapointe sold 15,127 shares of the company’s stock in a transaction dated Thursday, June 27th. The shares were sold at an average price of $3.27, for a total value of $49,465.29. Following the transaction, the vice president now owns 81,078 shares of the company’s stock, valued at $265,125.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, VP Michael R. Lapointe sold 26,265 shares of the company’s stock in a transaction dated Tuesday, June 25th. The shares were sold at an average price of $3.35, for a total transaction of $87,987.75. Following the completion of the transaction, the vice president now directly owns 81,078 shares in the company, valued at approximately $271,611.30. The disclosure for this sale can be found here. Corporate insiders own 9.50% of the company’s stock.
Hedge funds and other institutional investors have recently bought and sold shares of the business. B. Riley Wealth Management Inc. purchased a new position in shares of Research Frontiers during the first quarter valued at approximately $28,000. Catalyst Capital Advisors LLC purchased a new position in shares of Research Frontiers during the first quarter valued at approximately $164,000. Finally, Shufro Rose & Co. LLC raised its holdings in shares of Research Frontiers by 16.9% during the first quarter. Shufro Rose & Co. LLC now owns 165,750 shares of the technology company’s stock valued at $358,000 after purchasing an additional 24,000 shares during the last quarter. 6.81% of the stock is currently owned by institutional investors.
About Research Frontiers (NASDAQ:REFR)
Research Frontiers Incorporated develops and markets technology and devices to control the flow of light worldwide. The company develops and licenses suspended particle device (SPD-Smart) light-control technology to companies that manufacture and market the SPD-Smart chemical emulsion, light-control film made from the chemical emulsion, the light-control panels made by laminating the film, and electronics to power end-products incorporating the film, as well as lamination services for and the end-products, such as windows, skylights, and sunroofs.
Featured Story: What is the Dividend Aristocrat Index?
Receive News & Ratings for Research Frontiers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Research Frontiers and related companies with MarketBeat.com's FREE daily email newsletter.